CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,969,000 | -52.3% | 183,151 | -32.9% | 0.18% | -61.3% |
| Q4 2018 | $4,125,000 | -4.4% | 273,151 | +17.2% | 0.46% | -6.1% |
| Q3 2018 | $4,313,000 | +126.9% | 233,151 | +180.4% | 0.50% | +88.9% |
| Q2 2018 | $1,901,000 | -62.9% | 83,142 | -53.8% | 0.26% | -66.3% |
| Q1 2018 | $5,121,000 | +51.6% | 180,000 | +12.5% | 0.78% | +96.2% |
| Q4 2017 | $3,378,000 | -11.5% | 160,000 | -23.8% | 0.40% | -27.2% |
| Q3 2017 | $3,816,000 | +23.1% | 210,000 | +5.0% | 0.54% | +3.2% |
| Q2 2017 | $3,100,000 | +19.6% | 200,000 | +33.3% | 0.53% | +3.9% |
| Q1 2017 | $2,591,000 | – | 150,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |